The need for perforator treatment after VenaSeal and ClosureFast endovenous saphenous vein closure in CEAP 6 patients



      The authors have previously demonstrated that VenaSeal (Medtronic, Inc, Minneapolis, Minn) adhesive, compared with radiofrequency ablation (RFA, ClosureFast; Medtronic, Inc), in treatment of refluxing saphenous veins in CEAP 6 limbs, results in shorter healing times of venous ulcers. The authors hypothesize that the longer treated length possible with VenaSeal's nonthermal modality may affect the number of critical refluxing perforators contributing to the nonhealing wound. This follow-up study compares the need for follow-up treatment of perforator veins after saphenous vein treatment with either radiofrequency ablation (ClosureFast RFA) or adhesive closure (VenaSeal).


      A multi-institutional retrospective review of CEAP 6 patients who had closure of their saphenous veins from 2015 to 2020 was conducted. Patients who underwent follow-up treatment of perforator veins were grouped according to their method of initial management of their saphenous veins. The primary end point was incidence of a perforator procedure after ClosureFast or VenaSeal ablation. Secondary end points included sclerotherapy to facilitate wound healing. Bivariate analysis used the χ2 test, Fisher exact test, t-test, and Wilcoxon rank sum test. A P value of <.05 defined statistical significance.


      There were 119 CEAP 6 patients with saphenous closure: 51 limbs treated with VenaSeal and 68 with RFA. Median follow-up was 105 days (interquartile range: 44, 208). All limbs achieved wound healing during the study period. Mean time to wound healing post index procedure was shorter for VenaSeal than RFA (72 vs 293.8 days, P > .0009), as was median time (43 vs 104 days, P = .001). More limbs treated with RFA had previous known deep vein thrombosis (29% vs 10%, P = .009), deep venous insufficiency (82% vs 51%, P = .0003), and perforator reflux (57% vs 29%, P = .002). Limbs with identified follow-up perforator reflux treated with RFA had a higher prevalence of initially treated saphenous veins with RFA compared with those treated with VenaSeal (49% vs 27%, P = .003). There was no difference between the methods of vein closure and use of concurrent sclerotherapy.


      ClosureFast and VenaSeal are both effective and safe modalities of saphenous ablation, but VenaSeal treatment was associated with less perforator RFA intervention.


      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. O'Banion LA, Reynolds KB, Kochubey M, Cutler B, Tefera EA, Dirks R, Kiguchi MM. Treatment of superficial venous reflux in CEAP 6 patients: a comparison of cyanoacrylate glue and radiofrequency ablation techniques. J Vasc Surg Venous Lymphat Disord. 2021:pii: S2213-333X(21)00001-9. doi: 10.1016/j.jvsv.2020.12.082. Accessed January 13, 2021.

        • Harlander-Locke M.
        • Lawrence P.F.
        • Alktaifi A.
        • Jimenez J.C.
        • Rigberg D.
        • DeRubertis B.
        The impact of ablation of incompetent superficial and perforator veins on ulcer healing rates.
        J Vasc Surg. 2012; 55: 458-464
        • Labropoulos N.
        • Mansour M.A.
        • Kang S.S.
        • Gloviczki P.
        • Baker W.H.
        New insights into perforator vein incompetence.
        Eur J Vasc Endovasc Surg. 1999; 18: 228-234
        • Lawrence P.F.
        • Alktaifi A.
        • Rigberg D.
        • DeRubertis B.
        • Gelabert H.
        • Jimenez J.C.
        Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers.
        J Vasc Surg. 2011; 54: 737-742
        • Gloviczki P.
        • Comerota A.J.
        • Dalsing M.C.
        • Eklof B.G.
        • Gillespie D.L.
        • Gloviczki M.L.
        • et al.
        The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
        J Vasc Surg. 2011; 53: 2S-48S
        • Coleridge-Smith P.
        • Labropoulos N.
        • Partsch H.
        • Myers K.
        • Nicolaides A.
        • Cavezzi A.
        Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs—UIP consensus document. Part I. Basic principles.
        Eur J Vasc Endovasc Surg. 2006; 31: 83-92
        • Labropoulos N.
        • Tiongson J.
        • Pryor L.
        • Tassiopoulos A.K.
        • Kang S.S.
        • Ashraf Mansour M.
        • et al.
        Definition of venous reflux in lower-extremity veins.
        J Vasc Surg. 2003; 38: 793-798
        • Peden E.
        • Lumsden A.
        Radiofrequency ablation of incompetent perforator veins.
        Perspect Vasc Surg Endovasc Ther. 2007; 19: 73-77
        • Neglen P.
        • Thrasher T.L.
        • Raju S.
        Venous outflow obstruction: an underestimated contributor to chronic venous disease.
        J Vasc Surg. 2003; 38: 879-885
        • Bello M.
        • Scriven M.
        • Hartshorne T.
        • Bell P.R.
        • Naylor A.R.
        • London N.J.
        Role of superficial venous surgery in the treatment of venous ulceration.
        Br J Surg. 1999; 86: 755-759
        • Marrocco C.J.
        • Atkins M.D.
        • Bohannon W.T.
        • Warren T.R.
        • Buckley C.J.
        • Bush R.L.
        Endovenous ablation for the treatment of chronic venous insufficiency and venous ulcerations.
        World J Surg. 2010; 34: 2299-2304
        • O'Donnell Jr., T.F.
        The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption.
        J Vasc Surg. 2008; 48: 1044-1052
        • Tassiopoulos A.K.
        • Golts E.
        • Oh D.S.
        • Labropoulos N.
        Current concepts in chronic venous ulceration.
        Eur J Vasc Endovasc Surg. 2000; 20: 227-232
        • Stuart W.P.
        • Lee A.J.
        • Allan P.L.
        • Ruckley C.V.
        • Bradbury A.W.
        Most incompetent calf perforating veins are found in association with superficial venous reflux.
        J Vasc Surg. 2001; 34: 774-778
        • Iafrati M.D.
        • Pare G.J.
        • O'Donnell T.F.
        • Estes J.
        Is the nihilistic approach to surgical reduction of superficial and perforator vein incompetence for venous ulcer justified?.
        J Vasc Surg. 2002; 36: 1167-1174
        • Lawrence P.F.
        • Hager E.S.
        • Harlander-Locke M.P.
        • Pace N.
        • Jayaraj A.
        • Yohann A.
        • et al.
        Treatment of superficial and perforator reflux and deep venous stenosis improves healing of chronic venous leg ulcers.
        J Vasc Surg Venous Lymphat Disord. 2020; 8: 601-609
        • van Rij A.M.
        • Hill G.
        • Gray C.
        • Christie R.
        • Macfarlane J.
        • Thomson I.
        A prospective study of the fate of venous leg perforators after varicose vein surgery.
        J Vasc Surg. 2005; 42: 1156-1162
        • Gloviczki P.
        • Bergan J.J.
        • Rhodes J.M.
        • Canton L.G.
        • Harmsen S.
        • Ilstrup D.M.
        Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: lessons learned from the North American subfascial endoscopic perforator surgery registry. The North American Study Group.
        J Vasc Surg. 1999; 29: 489-502
        • Reitz K.M.
        • Salem S.
        • Mohapatra A.
        • Liang N.L.
        • Avgerinos E.D.
        • Singh M.J.
        • et al.
        Complete venous ulceration healing after perforator ablation does not depend on treatment modality.
        Ann Vasc Surg. 2021; 70: 109-115
        • Gibson K.
        • Elias S.
        • Adelman M.
        • Hager E.S.
        • Dexter D.J.
        • Vayuvegula S.
        • et al.
        A prospective safety and effectiveness study using endovenous laser ablation with a 400-mum optical fiber for the treatment of pathologic perforator veins in patients with advanced venous disease (SeCure trial).
        J Vasc Surg Venous Lymphat Disord. 2020; 8: 805-813
        • Guex J.J.
        • Isaacs M.N.
        Comparison of surgery and ultrasound guided sclerotherapy for treatment of saphenous varicose veins: must the criteria for assessment be the same?.
        Int Angiol. 2000; 19: 299-302
        • Masuda E.M.
        • Kessler D.M.
        • Lurie F.
        • Puggioni A.
        • Kistner R.L.
        • Eklof B.
        The effect of ultrasound-guided sclerotherapy of incompetent perforator veins on venous clinical severity and disability scores.
        J Vasc Surg. 2006; 43 (discussion: 556-7): 551-556
        • Hingorani A.P.
        • Ascher E.
        • Marks N.
        • Shiferson A.
        • Patel N.
        • Gopal K.
        • et al.
        Predictive factors of success following radio-frequency stylet (RFS) ablation of incompetent perforating veins (IPV).
        J Vasc Surg. 2009; 50: 844-848
        • Hager E.S.
        • Washington C.
        • Steinmetz A.
        • Wu T.
        • Singh M.
        • Dillavou E.
        Factors that influence perforator vein closure rates using radiofrequency ablation, laser ablation, or foam sclerotherapy.
        J Vasc Surg Venous Lymphat Disord. 2016; 4: 51-56
        • Olin J.W.
        • Beusterien K.M.
        • Childs M.B.
        • Seavey C.
        • McHugh L.
        • Griffiths R.I.
        Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study.
        Vasc Med. 1999; 4: 1-7
        • Kiguchi M.M.
        • Hager E.S.
        • Winger D.G.
        • Hirsch S.A.
        • Chaer R.A.
        • Dillavou E.D.
        Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.
        J Vasc Surg. 2014; 59: 1368-1376